NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Reviewed May 26, 2026

Levomilnacipran

Prescription ·Strong evidence ·Reviewed May 2026

Levomilnacipran is an extended-release SNRI approved for major depressive disorder in adults. Compared with many SNRIs it has prominent norepinephrine reuptake inhibition, so blood pressure, heart rate, urinary hesitation, and activation symptoms require attention. It carries the antidepressant boxed warning for suicidal thoughts and behaviors in pediatric and young adult patients.

What it's good for
  • Treatment of major depressive disorder in adults1
  • Improvement in depressed mood and low motivation
  • Once-daily extended-release administration3,1
What to watch for
  • Nausea
  • Constipation
  • Hyperhidrosis
  • Hypersensitivity to levomilnacipran, milnacipran, or formulation components1,3
  • Concurrent use with an MAOI, linezolid, or intravenous methylene blue3

The bottom line

Evidence rating strong. Most-documented uses: treatment of major depressive disorder in adults, improvement in depressed mood and low motivation, once-daily extended-release administration. 3 sources indexed (2005–2024), with 4 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Levomilnacipran inhibits reuptake of norepinephrine and serotonin, increasing monoaminergic signaling in CNS pathways involved in mood and motivation. It has greater norepinephrine than serotonin reuptake inhibition in vitro. It is metabolized partly by CYP3A4 and eliminated substantially by the kidney, so severe renal impairment and strong CYP3A4 inhibitors require dose limits.1,2

Class
Serotonin-norepinephrine reuptake inhibitor antidepressant
Dosing

Dosing & protocol.

Common range
Start 20 mg once daily for 2 days, then 40 mg once daily. Usual range is 40-120 mg once daily; do not exceed 80 mg once daily with strong CYP3A4 inhibitors.
Recommended form
Extended-release oral capsule swallowed whole once daily

Can be taken with or without food. Capsules should be swallowed whole and not opened, crushed, or chewed.3

Safety

Full safety detail.

Side effects

  • Nausea
  • Constipation
  • Hyperhidrosis
  • Increased heart rate
  • Increased blood pressure
  • Urinary hesitation or retention
  • Erectile dysfunction or delayed ejaculation
  • Serotonin syndrome with serotonergic agents
  • Hyponatremia
  • Bleeding risk
  • Activation of mania or hypomania

Contraindications

  • Hypersensitivity to levomilnacipran, milnacipran, or formulation components1,3
  • Concurrent use with an MAOI, linezolid, or intravenous methylene blue3
  • Do not start levomilnacipran within 14 days after stopping an MAOI3,1
  • Do not start an MAOI within 7 days after stopping levomilnacipran3
Interactions

Interaction records.

DangerousContraindicated

5-HTP

5-HTP can raise serotonin synthesis and add to levomilnacipran's serotonergic activity.

Recommendation: Avoid 5-HTP while taking levomilnacipran.

DangerousContraindicated

L-Tryptophan

Supplemental L-Tryptophan increases serotonin precursor availability and may increase serotonin syndrome risk with levomilnacipran.

Recommendation: Avoid L-Tryptophan supplements during therapy.

DangerousContraindicated

St. John's Wort

St. John's Wort can increase serotonergic activity and can induce drug-metabolizing pathways.

Recommendation: Do not combine St. John's Wort with levomilnacipran.

ModerateCaution

Ginkgo Biloba

Levomilnacipran may increase bleeding risk, and ginkgo may add mild antiplatelet effects.

Recommendation: Use cautiously, particularly with anticoagulants, antiplatelet therapy, frequent NSAIDs, bleeding disorders, or upcoming procedures.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Reviews & position papers

2
  • 1Levomilnacipran extended release for the treatment of major depressive disorderNeeds reviewNo linkAsnis GM, D'Arcy J · Drugs of Today · 2015

    Review summarizes pharmacology, efficacy, and noradrenergic adverse effects such as increased pulse and blood pressure.

  • 2The serotonin syndromeNeeds reviewNo linkBoyer EW, Shannon M · New England Journal of Medicine · 2005

    The review supports avoiding combinations of serotonergic drugs and supplements that increase serotonin production or signaling.

Reference material

1
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Levomilnacipran in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.